Answers are grounded in this paper and cite their sources.
Introduction: The incidence of neuroendocrine tumours (NETs) increased over the last years. Most of them are non-functioning, and the course of the disease is asymptomatic for a long time. This results in late diagnosis at an advanced stage. The aim of our study was the evaluation of selected circulating cytokines of interleukin-6 family - interleukin 6 (IL-6), oncostatin M (OSM), and cardiotrophin-1 (CT1) - in NETs. Material and methods: = 16; 20%). Serum IL-6, OSM, and CT1 concentrations were tested using ELISA. Our investigation into selected IL-6 family cytokines revealed differential modulation of signal transduction pathways. Conclusions: These findings suggest that despite utilising a common signalling transducer, individual IL-6 family cytokines exert distinct biological effects on neuroendocrine tumour development. Notably, IL-6 appears to promote tumourigenesis, while OSM and CT1 exhibit inhibitory effects on gastro-entero-pancreatic and bronchial neuroendocrine tumour development. Further studies are necessary to validate the diagnostic utility of IL-6 family cytokines in NETs.
No takes yet. Share an insight, caveat, or question.
Strzelczyk et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: